Monsanto (NYSE:MON) EVP Steven Mizell sold 8,100 shares of the company’s stock in a transaction dated Tuesday, January 9th. The shares were sold at an average price of $119.35, for a total transaction of $966,735.00. Following the completion of the sale, the executive vice president now owns 56,743 shares in the company, valued at approximately $6,772,277.05. The sale was disclosed in a filing with the SEC, which is accessible through this link.
Monsanto (NYSE:MON) traded up $0.71 on Thursday, reaching $119.54. 2,864,151 shares of the company traded hands, compared to its average volume of 3,843,681. The firm has a market capitalization of $52,620.00, a price-to-earnings ratio of 22.10, a price-to-earnings-growth ratio of 1.69 and a beta of 1.04. Monsanto has a 52-week low of $106.74 and a 52-week high of $122.79. The company has a current ratio of 1.28, a quick ratio of 0.79 and a debt-to-equity ratio of 1.05.
Monsanto (NYSE:MON) last released its quarterly earnings data on Thursday, January 4th. The basic materials company reported $0.41 earnings per share for the quarter, missing the consensus estimate of $0.42 by ($0.01). The business had revenue of $2.66 billion for the quarter, compared to analyst estimates of $2.77 billion. Monsanto had a return on equity of 40.13% and a net margin of 16.38%. Monsanto’s revenue was up .3% compared to the same quarter last year. During the same quarter last year, the company earned $0.21 EPS. equities analysts anticipate that Monsanto will post 5.79 EPS for the current year.
A number of institutional investors and hedge funds have recently added to or reduced their stakes in MON. Federated Investors Inc. PA raised its stake in Monsanto by 0.5% during the second quarter. Federated Investors Inc. PA now owns 9,555 shares of the basic materials company’s stock worth $1,131,000 after acquiring an additional 46 shares during the period. MUFG Securities EMEA plc acquired a new stake in Monsanto during the second quarter worth about $13,375,000. Key Square Capital Management LLC raised its stake in Monsanto by 4.1% during the second quarter. Key Square Capital Management LLC now owns 517,138 shares of the basic materials company’s stock worth $61,208,000 after acquiring an additional 20,209 shares during the period. Synovus Financial Corp raised its stake in Monsanto by 1.2% during the second quarter. Synovus Financial Corp now owns 7,211 shares of the basic materials company’s stock worth $854,000 after acquiring an additional 85 shares during the period. Finally, Northwestern Mutual Investment Management Company LLC grew its position in Monsanto by 320.1% in the 2nd quarter. Northwestern Mutual Investment Management Company LLC now owns 372,340 shares of the basic materials company’s stock worth $38,504,000 after purchasing an additional 283,703 shares during the last quarter. Hedge funds and other institutional investors own 75.34% of the company’s stock.
A number of brokerages have recently issued reports on MON. Barclays restated an “equal weight” rating and issued a $124.00 target price (up previously from $120.00) on shares of Monsanto in a research note on Thursday, October 5th. BMO Capital Markets restated a “buy” rating and issued a $128.00 target price on shares of Monsanto in a research note on Thursday, October 5th. Wells Fargo & Co upped their target price on shares of Monsanto from $107.50 to $118.00 and gave the company a “market perform” rating in a research note on Tuesday, October 10th. Macquarie lowered shares of Monsanto from an “outperform” rating to a “neutral” rating in a research note on Wednesday, October 4th. Finally, Zacks Investment Research upgraded shares of Monsanto from a “hold” rating to a “buy” rating and set a $132.00 target price on the stock in a research note on Thursday, September 14th. Eleven equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average target price of $126.40.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with MarketBeat.com's FREE daily email newsletter.